Overview
US medical liability insurer's Q1 net premiums written fell 6% yr/yr amid challenging market
Posts Q1 net profit compared with year-ago loss
Adjusted operating income for Q1 rose 87% yr/yr to $12.7 mln
Outlook
ProAssurance expects merger with The Doctors Company to close by June 30, 2026
Company says regulatory approvals for merger remain pending in California and Pennsylvania
ProAssurance continues to forgo business not meeting rate adequacy expectations in current market
Result Drivers
PREMIUM RATE INCREASES - Co said ongoing premium rate increases in medical professional liability and workers’ compensation supported operating performance
FAVORABLE RESERVE DEVELOPMENT - Qtr benefited from $3 mln of favorable prior year reserve development in medical professional liability business
HIGHER INVESTMENT INCOME - Net investment income rose 8.2% yr/yr, reflecting higher average book yields
Company press release: ID:nBw73DVkqa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Gross Premiums
$286.99 mln
Q1 Net Income
$8.46 mln
Q1 Adjusted Operating Income
Beat
$12.72 mln
$8.93 mln (1 Analyst)
Q1 Operating Expenses
$72.53 mln
Q1 Pretax Profit
$9.19 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the property & casualty insurance peer group is "buy."
Wall Street's median 12-month price target for Proassurance Corp is $25.00, about 1.4% above its May 4 closing price of $24.65
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 24 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)